This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Co., Ltd.. Active years: 1976.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1976
Title: Seiichi Yada: Innovator in Analgesic Development
Introduction
Seiichi Yada is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of unaddictive analgesics. His work focuses on creating compounds that can provide pain relief without the addictive properties commonly associated with traditional analgesics.
Latest Patents
Yada holds a patent for "2-Amino-1,2,3,4-tetrahydronaphthalene derivatives - 6,7-Benzomorphan derivatives." This innovative patent describes a process for preparing these derivatives from aromatic aminoketones through several steps of reactions. Most of the intermediates involved in this process are new compounds, showcasing Yada's creativity and expertise in the field. Additionally, the patent discloses a process for preparing 2-benzyl-1,2,5,6-tetrahydropyridine derivatives, which are known as intermediates for the preparation of 6,7-benzomorphan derivatives.
Career Highlights
Seiichi Yada is associated with Kyowa Hakko Kogyo Co., Ltd., a company known for its commitment to research and development in the pharmaceutical industry. His work at the company has allowed him to focus on innovative solutions for pain management, contributing to advancements in the field.
Collaborations
Yada has collaborated with notable colleagues such as Kyoichi Fujii and Shiro Kudo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.
Conclusion
Seiichi Yada's contributions to the development of unaddictive analgesics highlight his innovative spirit and dedication to improving pain management solutions. His work continues to influence the pharmaceutical industry and offers hope for safer pain relief options in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
